nach oben

Erschienen in:

01.09.2007 | CPC

Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome

A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery

verfasst von: Diane George, MD, Lisa Vasanth, MD, Doruk Erkan, MD, Anne Bass, MD, Jane Salmon, MD, Michael D. Lockshin, MD

Erschienen in: HSS Journal ® | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Excerpt

A 29-year-old woman (gravida 1, para 0) was transferred to New York Presbyterian Hospital (NYPH) for the evaluation of complete vision loss in the left eye, which occurred 4 days after an emergency medical abortion because of hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. …

Salafia CM, Pezzulo JC, Lopez-Zeno JA, Minior VK et al (1995) Placental pathologic features of preterm pre-eclampsia. Am J Obstet Gynecol 173(4):1097–1105PubMedCrossRef

Shanklin DR, Sibai BM (1989) Ultrastructural aspects of preeclampsia I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 161(3):735–741PubMed

Martin JN Jr, Rinehart BK, May WL et al (1999) The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 180(6 Pt 1):1373–1384PubMedCrossRef

Curtin WM, Weinstein L (1999) A Review of HELLP syndrome: State of the Art. J Perinatol 19(2):138–143PubMedCrossRef

Baxter JK, Weinstein L (2004) HELLP syndrome: the state of the art. Obstet Gynecol Surv 59(12):838–845PubMedCrossRef

Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309–1311PubMedCrossRef

Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306PubMedCrossRef

Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80(4):614–620PubMed

Le Thi Thuong D, Tieulie N, Costedoat N et al (2005) The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64(2):273–278PubMedCrossRef

10.

Huong DL, Wechsler B, Bletry O et al (2001) A study of 75 pregnancies in patients with the antiphospholipid syndrome. J Rheumatol 28:2025–2030PubMed

11.

Branch DW, Scott JR, Kochenour NK et al (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 313(21):1322–1326PubMedCrossRef

12.

Rote NS, Walter A, Lyden TW et al (1992) Antiphospholipid antibodies—lobsters or red herrings. Am J Reprod Immunol 28(1):31–37PubMed

13.

Sammaritano LR (2001) Update on the management of the pregnant patient with antiphospholipid antibody. Curr Rheumatol Rep 3(3):213–221PubMedCrossRef

14.

Erkan D (2002) The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: review of the literature and management strategies. Curr Rheumatol Rep 4(5):379–386PubMedCrossRef

15.

Magid MS, Kaplan C, Sammaritano LR et al (1998) Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 179(1):226–234PubMedCrossRef

16.

Van Horn JT, Craven C, Ward K et al (2004) Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid like syndromes. Placenta 25(7):642–648PubMedCrossRef

17.

Infante-Rievard C, David M, Gauthier R et al (1991) Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med 325(15):1063–1066CrossRef

18.

Rand JH, Wu XX, Andree HA et al (1997) Pregnancy loss in the antiphospholipid–antibody syndrome—a possible thrombogenic mechanism. N Engl J Med 337(3):154–160.PubMedCrossRef

19.

Simantov R, LaSala J, Lo SK et al (1995) Activation of cultured vascular endothelium by antiphospholipid antibodies. J Clin Invest 96:2211–2219PubMedCrossRef

20.

Pierangeli SS, Colden-Stanfield M, Liu X et al (1999) Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99(15):1997–2002PubMed

21.

Branch DW, Dudley DJ, Mitchell MD et al (1990) Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BABL/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 163(1 Pt 1):210–216PubMed

22.

Holers VM, Girardi G, Guthridge GM et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195(2):211–220PubMedCrossRef

23.

Girardi G, Redecha P, Berman J et al (2004) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112(11):1644–1654CrossRef

24.

Pierangeli SS, Girardi G, Vega-Ostertag M et al (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52(7):2120–2124PubMedCrossRef

25.

Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10(11):1222–1226PubMedCrossRef

26.

Derekson RH, De Groot PG, Kater L, Nieuwenhuis HK (1993) Patients with Antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 52:689–692

27.

Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103(5 Pt 1):981-991PubMed

Titel: Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome
A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery
verfasst von: Diane George, MD
Lisa Vasanth, MD
Doruk Erkan, MD
Anne Bass, MD
Jane Salmon, MD
Michael D. Lockshin, MD
Publikationsdatum: 01.09.2007
Verlag: Springer-Verlag
Erschienen in: HSS Journal ® / Ausgabe 2/2007
Print ISSN: 1556-3316
Elektronische ISSN: 1556-3324
DOI: https://doi.org/10.1007/s11420-007-9043-6

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome

A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery

Excerpt

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

Update Orthopädie und Unfallchirurgie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Etiology and Surgical Interventions for Stiff Total Knee Replacements

The Coronal Plane High Tibial Osteotomy. Part II: A Comparison of Axial Rotation with the Opening Wedge High Tibial Osteotomy

Physical Therapy and Complementary and Alternative Medicine: An Educational Tool for Enhancing Integration

Intra-articular Corticosteroid Injection for the Treatment of Idiopathic Adhesive Capsulitis of the Shoulder

Custom-made Articulating Spacer in Two-stage Revision Total Knee Arthroplasty. An Early Follow-up of 14 Cases of at Least 1 Year After Surgery

Professionalism and Medicine

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

Update Orthopädie und Unfallchirurgie